FiercePharmaAsia—Merck-Eisai’s Lenvima deal, JW’s $90M series A, novel HIV drug

Merck signed a deal potentially worth $5.8 billion for half of Lenvima's sales; Juno and WuXi AppTec's CAR-T joint venture got $90 million in a series A; the FDA approved TaiMed Biologics’ novel HIV drug Trogarzo manufactured by WuXi Biologics; plus more pharma industry news from Asia.Original Article